The preparation and evaluation of poly(ϵ-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Controlled Release

• Publication date

  2000-04-03

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/S0168-3659(99)00253-9
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Influence of different physicochemical conditions on the release of indium oxine from nanocapsules.

  1998cited by this paper
• Development of tablets for controlled joint release of nifedipine and atenolol.

  1998cited by this paper
• Preparation and in vitro dissolution profile of dual polymer (Eudragit RS100 and RL100) microparticles of diltiazem hydrochloride.

  1998cited by this paper
• Eudragit microcapsules of nifedipine and its dispersions in HPMC-MCC : Physicochemical characterization and drug release studies

  1997cited by this paper
• Determination of the physical state of drug in microcapsule and microsphere formulations.

  1997cited by this paper
• The antihypertensive effect of orally administered nifedipine‐loaded nanoparticles in spontaneously hypertensive rats

  1997cited by this paper
• Protein release from poly(epsilon-caprolactone) microspheres prepared by melt encapsulation and solvent evaporation techniques: a comparative study.

  1997cited by this paper
• Albumin release from bioerodible hydrogels based on semi-interpenetrating polymer networks composed of poly(ϵ-caprolactone) and poly(ethylene glycol) macromer

  1997cited by this paper
• AN INVESTIGATION OF THE EFFECTS OF SOME PROCESS VARIABLES ON THE MICROENCAPSULATION OF PROPRANOLOL HYDROCHLORIDE BY THE SOLVENT EVAPORATION METHOD

  1995cited by this paper
• Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems.

  1995cited by this paper
• Formulation, preparation and dissolution characteristics of propranolol hydrochloride microspheres.

  1994cited by this paper
• Effect of the emulsion stability on the morphology and porosity of semicrystalline poly l-lactide microparticles prepared by w/o/w double emulsion-evaporation

  1994cited by this paper
• Microencapsulation of chlorpheniramine maleate, a drug with intermediate solubility properties, by a non-aqueous solvent evaporation technique

  1994cited by this paper
• 1993 guidelines for the management of mild hypertension. Memorandum from a World Health Organization/International Society of Hypertension meeting. Guidelines Subcommittee of the WHO/ISH Mild Hypertension Liaison Committee.

  1993cited by this paper
• The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting.

  1993cited by this paper
• Influence of manufacturing parameters on the size characteristics and the release profiles of nifedipine from poly(DL-lactide-co-glycolide) microspheres

  1993cited by this paper
• Preparation of multi-phase microspheres of poly(D,L-lactic acid) and poly(D,L-lactic-co-glycolic acid) containing a W/O emulsion by a multiple emulsion solvent evaporation technique.

  1992cited by this paper
• Poly-ε-caprolactone and its copolymers

  1990cited by this paper
• Biodegradable polymers as drug delivery systems

  1990cited by this paper
• Encapsulation of water-soluble drugs by a modified solvent evaporation method. I. Effect of process and formulation variables on drug entrapment.

  1990cited by this paper
• Solvent selection in the preparation of poly(dl-lactide) microspheres prepared by the solvent evaporation method

  1988cited by this paper
• Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. I. Methods and morphology.

  1987cited by this paper
• Polylactic acid microspheres containing quinidine base and quinidine sulphate prepared by the solvent evaporation technique. II. Some process parameters influencing the preparation and properties of microspheres.

  1987cited by this paper
• Nifedipine Kinetics and Bioavailability After Single Intravenous and Oral Doses in Normal Subjects

  1983cited by this paper
• Effectiveness of combined nifedipine and propranolol treatment in hypertension.

  1983cited by this paper
• The Pharmacological Basis of Therapeutics

  1976cited by this paper

• Biopolymers and synthetic polymeric materials in wound healing: cellular mechanisms and therapeutic potential

  2025cites this paper
• Effect of poly(ε-caprolactone) microspheres on population pharmacokinetic/pharmacodynamic model of a simple coumarin

  2024cites this paper
• A comparative analysis of PLA and PCL microparticles for hydrophilic and hydrophobic drugs

  2024cites this paper
• Two-step emulsification for the fabrication of homogeneous PCL microspheres encapsulating geniposidic acid with antioxidant properties

  2024cites this paper
• Synthesis of cefixime loaded PCL/HPMC blend nanoparticles: a controlled release study and in vitro anti-bacterial evaluation

  2024cites this paper
• Polymer Delivery Systems for Long-Acting Antiretroviral Drugs

  2024cites this paper
• The concentration and type of emulsifier rules the oil/water and water/oil/water emulsion size distribution

  2023cites this paper
• PREPARATION AND EVALUATION OF PROPRANOLOL HCL AND CARBAMAZEPINE RELEASE PROFILES FROM POLY(Є-CAPROLACTONE) MICROPARTICLE BLENDS SYSTEM

  2023cites this paper
• Prickly pear seed oil (PPSO) encapsulated by biodegradable polymer Poly-hydroxy-butyrate-co-valerate (PHBV)

  2022cites this paper
• Impact of dispersion time interval and particle size on release profiles of propranolol HCl and carbamazepines from microparticle blends system

  2022cites this paper
• Tissue engineering applications

  2021cites this paper
• Targeting Solid Lipid Nanoparticles with Anisamide for Docetaxel Delivery to Prostate Cancer: Preparation, Optimization, and In-vitro Evaluation

  2021cites this paper
• CCID_A_229054 31..48

  2020cites this paper
• Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer

  2020cites this paper
• Polycaprolactone: How a Well-Known and Futuristic Polymer Has Become an Innovative Collagen-Stimulator in Esthetics

  2020cites this paper
• In vitro anti-leukemic assessment and sustained release behaviour of cytarabine loaded biodegradable polymer based nanoparticles.

  2020cites this paper
• Elements of material science and polymeric biomaterials

  2020cites this paper
• Molecular Dynamics Simulation, Characterization and In Vitro Drug Release of Isoniazid Loaded Poly-ε-caprolactone Magnetite Nanocomposite

  2020cites this paper
• Shear Speed-Regulated Properties of Long-Acting Docetaxel Control Release Poly (Lactic-Co-Glycolic Acid) Microspheres

  2020cites this paper
• Formulation composition, manufacturing process, and characterization of poly(lactide-co-glycolide) microparticles.

  2020cites this paper
• Development of a dissolution method based on lipase for preclinical level A IVIVC of oral poly(ε-caprolactone) microspheres

  2019cites this paper
• Controlled drug release carriers based on PCL/PEO/PCL block copolymers

  2019cites this paper
• Boosting Drug Discovery for Parkinson’s: Enhancement of the Delivery of a Monoamine Oxidase-B Inhibitor by Brain-Targeted PEGylated Polycaprolactone-Based Nanoparticles

  2019cites this paper
• Biodegradable synthetic polyesters in the technology of controlled dosage forms of antihypertensive drugs – the overview

  2019cites this paper
• Functionalized polymers for drug/gene-delivery applications

  2019cites this paper
• Parameter Optimization Of Injectable Polycaprolactone Microspheres Containing Curcumin Using Response Surface Methodology

  2018cites this paper
• DEVELOPMENT AND CHARACTERIZATION OF GASTRORETENTIVE FLOATING MICROSPHERE FOR CONTROLLED RELEASE OF METOCLOPRAMIDE HYDROCHLORIDE

  2018cites this paper
• Optimization of valsartan encapsulation in biodegradables polyesters using Box-Behnken design.

  2018cites this paper
• Nanoencapsulation of Drugs in PCL with different water soluble Polymeric blends

  2018cites this paper
• Introduction to bioresorbable polymers for biomedical applications

  2017cites this paper
• Bottom-up Structural Design of Crystalline Drug-Excipient Composite Microparticles via Microfluidic Droplet-based Processing

  2017cites this paper
• Optimization and characterization of primaquine–loaded solid lipid nanoparticles (SLN) for liver schinonticide targeting by freeze drying

  2017cites this paper
• ENCAPSULATION OF VENLAFAXINE HCL IN TO POLY-E-CAPROLACTONE MICROSPHERES BY W/O/W AMD W/O/O EMULSION SOLVENT EVAPORATION TECHNIQUE AND COMPARISON FOR ITS CONTROLLED RELEASE PROPERTIES.

  2017cites this paper
• Synthesis and Physicochemical Characterisation of Poly (?-caprolactone) Nanoparticles for Delivery of Propranolol

  2017influential citation
• Optimization and Characterization of Primaquine-Loaded Solid Lipid Nanoparticles (SLN) for Liver Schinonticide Targeting by Freeze Drying

  2017cites this paper
• Design and evaluation of gamma-sterilized vancomycin hydrochloride-loaded poly(ɛ-caprolactone) microspheres for the treatment of biofilm-based medical device-related osteomyelitis

  2017cites this paper
• Drug delivery systems based on poly(-caprolactone) for cancer treatment

  2017cites this paper
• Development of in vitro‐in vivo correlation of parenteral naltrexone loaded polymeric microspheres

  2017influential citation
• Development and Characterization of a Polyester-Based Implant for Controlled Drug Release

  2017cites this paper
• Comparison of Freeze and Spray Drying to Obtain Primaquine-Loaded Solid Lipid Nanoparticles

  2017cites this paper
• Glycoproteins functionalized natural and synthetic polymers for prospective biomedical applications: A review.

  2017cites this paper
• Efficient cutaneous wound healing using bixin-loaded PCL nanofibers in diabetic mice.

  2017cites this paper
• PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles.

  2016cites this paper
• Topical ocular delivery of a COX-II inhibitor via biodegradable nanoparticles

  2016cites this paper
• Poly-e-caprolactone-loaded miglitol microspheres for the treatment of type-2 diabetes mellitus using the response surface methodology

  2016cites this paper
• Development of low density azithromycin-loaded polycaprolactone microparticles for pulmonary delivery

  2016cites this paper
• Synthesis, characterizations, in vitro and in vivo evaluation of Etoricoxib-loaded Poly (Caprolactone) microparticles – a potential Intra-articular drug delivery system for the treatment of Osteoarthritis

  2016cites this paper
• Biodegradable microparticles preparation by double emulsification—Solvent extraction method: A Systematic study

  2016cites this paper
• Development and characterization of enteric-coated microparticles of biochanin A for their beneficial pharmacological potential in estrogen deficient-hypertension

  2016cites this paper
• Magnetically responsive polycaprolactone nanoparticles for progesterone screening in biological and environmental samples using gas chromatography

  2016cites this paper
• Molecular modeling and cytotoxicity of diffractaic acid: HP-β-CD inclusion complex encapsulated in microspheres.

  2016cites this paper
• Synthesis and characterization of the antitubercular phenazine lapazine and development of PLGA and PCL nanoparticles for its entrapment.

  2016cites this paper
• Development, characterization and assessment of botulinum toxin type A incorporated in nanocarriers

  2016influential citation
• The parameters influencing the morphology of poly(ɛ-caprolactone) microspheres and the resulting release of encapsulated drugs.

  2015influential citation
• Preparation and Characterization of Nanoscale Complex Liposomes Containing Medium-Chain Fatty Acids and Vitamin C

  2015cites this paper
• Bioactive Glass Nanoparticles as a New Delivery System for Sustained 5-Fluorouracil Release: Characterization and Evaluation of Drug Release Mechanism

  2015cites this paper
• Citation for published version: Alhusein, N, Blagbrough, IS & De Bank, PA 2012, 'Electrospun matrices for localised controlled drug delivery: release of tetracycline hydrochloride from layers of polycaprolactone and poly(ethylene-co-vinyl acetate)' Drug

  2015cites this paper
• Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms

  2015cites this paper
• Polycaprolactone multicore-matrix particle for the simultaneous encapsulation of hydrophilic and hydrophobic compounds produced by membrane emulsification and solvent diffusion processes.

  2015cites this paper
• Microencapsulation d’agent antimicrobien pour le développement de conditionnements primaires fonctionnalisés

  2015cites this paper
• Preparation of submicron particles for theranostic applications : imaging and therapy

  2015cites this paper
• Biodegradable PHBV/PEO Blend Microspheres for Controlled Release of Bosentan Monohydrate: Preparation, Characterization and In Vitro Release Studies

  2014cites this paper
• Controlled-release and antibacterial studies of doxycycline-loaded poly(ε-caprolactone) microspheres

  2014cites this paper
• Preparation of uniform poly-caprolactone Microparticles by membrane emulsification/solvent diffusion process

  2014cites this paper
• Particles from preformed polymers as carriers for drug delivery

  2014cites this paper
• Design, characterization and in-vitro evaluation of different cellulosic acrylic and methacrylic polymers loaded aceclofenac microspheres.

  2014cites this paper
• Preparation and in-vitro Evaluation of Poly--Caprolactone Nanoparticles Containing Atorvastatin Calcium

  2014cites this paper
• Advanced progress of microencapsulation technologies: in vivo and in vitro models for studying oral and transdermal drug deliveries.

  2014cites this paper
• Polymeric nanoparticles-embedded organogel for roxithromycin delivery to hair follicles.

  2014cites this paper
• Protein capsules with cross-linked, semipermeable, and enzyme-degradable surface barriers for controlled release.

  2014cites this paper
• Formulation and characterization of ethylcellulose microparticles containing .l-alanyl- l-glutamine peptide

  2014influential citation
• A NOVEL BIODEGRADABLE MICROPARTICULATED DRUG DELIVERY SYSTEM: ON REVIEW

  2014cites this paper
• Preparation and in-vitro Evaluation of Poly--Caprolactone Nanoparticles Containing Atorvastation Calcium

  2014cites this paper
• ETOPOSIDE-LOADED NANOPARTICLES MADE FROM POLY-E- CAPROLACTONE (PCL): FORMULATION, CHARACTERIZATION, IN VITRO DRUG RELEASE FOR CONTROLLED DRUG DELIVERY SYSTEM

  2014cites this paper
• Peptide Nanostructured Conjugates for Therapeutics

  2013cites this paper
• Review Article A Review on Various Techniques of Microencapsulation

  2013cites this paper
• Research Article Fabrication and Evaluation of Atorvastatin Calcium Loaded Sustained Release Microspheres using O/W/O Double Emulsion Solvent Evaporation Technique

  2013cites this paper
• Study of microparticle preparation by the solvent evaporation method usingfocused beam reflectance measurement (FBRM)

  2013cites this paper
• Influence of polymer blends on the characterization of gliclazide – encapsulated into poly (Æ-caprolactone) microparticles

  2013cites this paper
• Preparation and Characterization of Nanoliposomes Entrapping Medium-Chain Fatty Acids and Vitamin C by Lyophilization

  2013cites this paper
• Development of poly(butylene succinate) microspheres for delivery of levodopa in the treatment of Parkinson's disease.

  2013cites this paper
• Influence of PCL on the material properties of collagen based biocomposites and in vitro evaluation of drug release.

  2013cites this paper
• AB, BAB and (AB)3 poly(ε-caprolactone)-based block copolymers with functionalized poly(meth)acrylate segments

  2013cites this paper
• ASSESSMENT OF MICROPARTICULATE DRUG DELIVERY SYSTEM OF PROPRANOLOL HYDROCHLORIDE PREPARED BY MULTIPLE SOLVENT EMULSION TECHNIQUE

  2013cites this paper
• Nanopartículas de PCL com acetato de hidrocortisona como uma terapia dermatológica inovadora para a dermatite atópica

  2013cites this paper
• Microparticles and Nanoparticles

  2013cites this paper
• Electrospun matrices for localised controlled drug delivery: release of tetracycline hydrochloride from layers of polycaprolactone and poly(ethylene-co-vinyl acetate)

  2012cites this paper
• Tamoxifen-loaded nanoparticles based on a novel mixture of biodegradable polyesters: characterization and in vitro evaluation as sustained release systems

  2012cites this paper
• Preparation and characterization of amoxicillin mucoadhesive microparticles using solution-enhanced dispersion by supercritical CO2

  2012cites this paper
• Evaluation of subcutaneous forms in the improvement of pharmacokinetic profile of warfarin.

  2012cites this paper
• Poly-є-caprolactone based formulations for drug delivery and tissue engineering: A review.

  2012cites this paper
• Development of Novel Controlled Release Gliclazide-Loaded poly(ε-caprolactone) Microparticles: Effect of Polymer Blends

  2012cites this paper
• Drug and Protein Encapsulation by Emulsification: Technology Enhancement Using Foam Formulations

  2012cites this paper
• Membranes for the preparation of emulsions and particles

  2012cites this paper
• Aplicação do poli(ε-caprolactona) com estrutura estrelada para obtenção de microesferas biorreabsorvíveis

  2012cites this paper
• Green tea encapsulation by means of high pressure antisolvent coprecipitation

  2011cites this paper
• Development characterizations and evaluation of Poly(-ϵ-caprolactone)-based microspheres for hepatitis B surface antigen delivery

  2011cites this paper
• A Novel Antimicrobial Nano-Composite Porous Material for Bone Repair

  2011cites this paper
• Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis.

  2011cites this paper
• Performance of biodegradable microcapsules of poly(butylene succinate), poly(butylene succinate-co-adipate) and poly(butylene terephthalate-co-adipate) as drug encapsulation systems.

  2011cites this paper